Can a simple additive make eye surgery safer for the heart?

NCT ID NCT07675616

First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time

Summary

This trial tests whether adding dexmedetomidine or magnesium sulphate to lidocaine for a peribulbar block (anesthesia around the eye) helps keep heart rate and blood pressure steady during dacryocystorhinostomy (tear duct surgery) under general anesthesia. Sixty adults undergoing elective surgery will be randomly assigned to receive one of three mixtures. The goal is to find which additive provides better hemodynamic stability, reducing risks like reflex changes in heart rate during surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
dexmedetomidine and magnesium sulphate
What this could lead to
If one additive works better, it could become a standard way to keep patients stable during eye surgery under general anesthesia.
What could go wrong
This is a small, early-phase trial with only 60 participants, so results may not apply to everyone. Both additives are already used in other settings, so no major breakthrough is expected.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DACRYOCYSTORHINOSTOMY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Cairo University

    RECRUITING

    Cairo, 12613, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.